Literature DB >> 27010230

Preoperative intravitreal injection of ranibizumab for patients with severe proliferative diabetic retinopathy contributes to a decreased risk of postoperative neovascular glaucoma.

Qianyi Lu1, Chen Zou1, Hui Cao1, Minjie Zhao1, Siqing Yu1, Qinghua Qiu1, Xun Xu1, Zhi Zheng1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27010230     DOI： 10.1111/aos.13019

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN： 1755-375X            Impact factor:   3.761


× No keyword cloud information.
  4 in total

1.  Differences in Vitreous Protein Profiles in Patients With Proliferative Diabetic Retinopathy Before and After Ranibizumab Treatment.

Authors:  Xinping She; Chen Zou; Zhi Zheng
Journal:  Front Med (Lausanne)       Date:  2022-05-27

2.  Difference in the Vitreal Protein Profiles of Patients with Proliferative Diabetic Retinopathy with and without Intravitreal Conbercept Injection.

Authors:  Chen Zou; Minjie Zhao; Jingjing Yu; Dandan Zhu; Yunzhi Wang; Xinping She; Yanan Hu; Zhi Zheng
Journal:  J Ophthalmol       Date:  2018-04-19       Impact factor: 1.909

Review 3.  Proteomic Biomarkers of Retinal Inflammation in Diabetic Retinopathy.

Authors:  Hannah Youngblood; Rebekah Robinson; Ashok Sharma; Shruti Sharma
Journal:  Int J Mol Sci       Date:  2019-09-25       Impact factor: 5.923

4.  Change of ranibizumab-induced human vitreous protein profile in patients with proliferative diabetic retinopathy based on proteomics analysis.

Authors:  Chen Zou; Changjing Han; Minjie Zhao; Jingjing Yu; Lin Bai; Yuan Yao; Shuaixin Gao; Hui Cao; Zhi Zheng
Journal:  Clin Proteomics       Date:  2018-03-09       Impact factor: 3.988
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.